Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Gilead Sciences vs. Pfizer

TheMotleyFool

0 0

You might think that Gilead Sciences (NASDAQ: GILD) and Pfizer (NYSE: PFE) would have delivered tremendous gains in 2020. After all, Gilead launched a much-heralded treatment for COVID-19 with Veklury (remdesivir), and Pfizer rolled out an even more anxiously awaited coronavirus vaccine. But neither of these stocks performed well last year. Gilead's shares sank 10%, while Pfizer's shares slipped nearly 1%.

The past is the past, though. Which of these stocks is the better pick moving forward? Here's how Gilead and Pfizer stack up against each other.

Image source: Getty Images.

Source Fool.com

Like: 0

PFE

Share